STRS Ohio’s Seres Therapeutics MCRB Stock Holding History

STRS Ohio’s Portfolio MCRB Stock Details MCRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,685	Closed	-$601K	–	2036
2022 Q3	$601K	Sell	4,685 -4,305	-48%	-$441K	﹤0.01%	1230
2022 Q2	$616K	Buy	8,990 +3,850	+75%	+$332K	﹤0.01%	1236
2022 Q1	$731K	Buy	5,140 +205	+4%	+$31.5K	﹤0.01%	1246
2021 Q4	$822K	Buy	+4,935	New	+$784K	﹤0.01%	1247
2021 Q1	–	Sell	-295	Closed	-$144K	–	2236
2020 Q4	$144K	Hold	295	–	–	﹤0.01%	1815
2020 Q3	$167K	Buy	295 +270	+1,080%	+$89.8K	﹤0.01%	1714
2020 Q2	$2K	Hold	25	–	–	﹤0.01%	2137
2020 Q1	$1K	Hold	25	–	–	﹤0.01%	2005
2019 Q4	$1K	Hold	25	–	–	﹤0.01%	2046
2019 Q3	$2K	Hold	25	–	–	﹤0.01%	2058
2019 Q2	$1K	Hold	25	–	–	﹤0.01%	2100
2019 Q1	$3K	Hold	25	–	–	﹤0.01%	2032
2018 Q4	$2K	Hold	25	–	–	﹤0.01%	2060
2018 Q3	$3K	Hold	25	–	–	﹤0.01%	2092
2018 Q2	$4K	Hold	25	–	–	﹤0.01%	2101
2018 Q1	$3K	Hold	25	–	–	﹤0.01%	1864
2017 Q4	$5K	Hold	25	–	–	﹤0.01%	1861
2017 Q3	$8K	Hold	25	–	–	﹤0.01%	1896
2017 Q2	$5K	Hold	25	–	–	﹤0.01%	1916
2017 Q1	$5K	Hold	25	–	–	﹤0.01%	1869
2016 Q4	$4K	Hold	25	–	–	﹤0.01%	1901
2016 Q3	$6K	Sell	25 -115	-82%	-$40.4K	﹤0.01%	1882
2016 Q2	$81K	Hold	140	–	–	﹤0.01%	1707
2016 Q1	$74K	Hold	140	–	–	﹤0.01%	1726
2015 Q4	$98K	Hold	140	–	–	﹤0.01%	1687
2015 Q3	$82K	Buy	+140	New	+$114K	﹤0.01%	1693

Other funds holding MCRB

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

STRS Ohio's MCRB Position: Q4 2022 in Review

STRS Ohio sold out of Seres Therapeutics (MCRB) in Q4 2022, closing a stake of 4,685 shares — an estimated $601K sold.

STRS Ohio first reported a position in MCRB in Q3 2015 and held it in 26 quarters. The position peaked at $822K in Q4 2021. 123 funds tracked by Wall St. Rank hold MCRB as of Q4 2022.

STRS Ohio reported no remaining Seres Therapeutics position as of Q4 2022 after selling out during the quarter.
STRS Ohio sold 4,685 Seres Therapeutics shares in Q4 2022, an estimated $601K.
STRS Ohio first reported a position in Seres Therapeutics in Q3 2015 and held it in 26 quarters.
STRS Ohio's Seres Therapeutics position peaked at $822K in Q4 2021.
123 funds tracked by Wall St. Rank held Seres Therapeutics as of Q4 2022.

Based on STRS Ohio's 13F filing for Q4 2022, filed 26 Jan 2023.